Start an analysis for IDXX
Idexx Laboratories Inc
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $53.8bnEST | 30-Sep-26 | 10-Q filed 02-Nov-26 |
| Remaining authorization | $1.6bnEST | 30-Sep-26 | 10-Q filed 02-Nov-26 |
| Program expiry | n/a | — | |
| Repurchased last quarter | $112m | 31-Aug-26 | 10-Q filed 02-Nov-26 |
| Has used an ASR | No | — |
Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 13-Aug-99 | $53.8bnEST 78.0m sh | $1.6bnEST 2.4m sh left | n/a | Board of Directors has approved the repurchase of up to 78 million shares of common stock in the open market or in negotiated transactions pursuant to the Company's share repurchase program. The initial program was approved and announced on August 13, 1999, and the maximum number of shares that may be purchased under the program has been increased by the Board of Directors on numerous occasions.…10-Q filed 02-Nov-26 |
Open-market repurchases
- Apr ’26
- May ’26
- Jun ’26
- Jul ’26
- Aug ’26
| Month ended | Shares | Withheld & other | Avg price | ≈ Value | Source |
|---|---|---|---|---|---|
| 31-Aug-26 | 26,400 | — | $585.84 | $15m | 10-Q filed 02-Nov-26 |
| 31-Jul-26 | 172,200 | — | $559.54 | $96m | 10-Q filed 02-Nov-26 |
| 30-Jun-26 | 84,784 | 484 | $558.85 | $47m | 10-Q filed 04-Aug-26 |
| 31-May-26 | 140,545 | 45 | $562.67 | $79m | 10-Q filed 04-Aug-26 |